Publications by authors named "Dion Zappe"

Claim this Profile
A
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.
Akshay S Desai, Adam D Karns, Jolita Badariene, Ahmad Aswad, Joel M Neutel, Dion H Zappe

JAMA· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
George L Bakris, Manish Saxena, Anil Gupta, Fadi Chalhoub, Jongtae Lee, Dion Zappe

JAMA· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of nonalcoholic steatohepatitis (NASH) in the United States.
Elliot B Tapper, Nancy Krieger, Raymond Przybysz, Nate Way, Jennifer Cai, Dion Zappe

BMC Gastroenterol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension.
Eirik Olsen, Björn Holzhauer, Stevo Julius, Sverre E Kjeldsen, Anne Cecilie K Larstorp, Dion Zappe

Blood Press· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk.
Eirik Olsen, Björn Holzhauer, Stevo Julius, Sverre E Kjeldsen, Anne Cecilie K Larstorp, Dion Zappe

Blood Press· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study.
Maria-Magdalena Balp, Nancy Krieger, Raymond Przybysz, Nate Way, Jennifer Cai, Dion Zappe

JHEP Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
Robert D Brook, Niko Kaciroti, George Bakris, Björn Dahlöf, Bertram Pitt, Dion H Zappe

J Am Heart Assoc· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Crystalline Valsartan/Sacubitril (LCZ696) Compared With Placebo and Combinations of Free Valsartan and Sacubitril in Patients With Systolic Hypertension: The RATIO Study.
Joseph L Izzo, Dion H Zappe, Yan Jia, Kudsia Hafeez, Jack Zhang

J Cardiovasc Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study.
Bryan Williams, John R Cockcroft, Kazuomi Kario, Dion H Zappe, Patrick C Brunel

Hypertension· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Age and Race on 24-Hour Ambulatory Blood Pressure Responses to Valsartan, Hydrochlorothiazide, and Their Combination: Implications for Clinical Practice.
Joseph L Izzo, Yan Jia, Dion H Zappe

J Clin Hypertens (Greenwich)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Sverre E Kjeldsen, Eivind Berge, Sripal Bangalore, Franz H Messerli, Giuseppe Mancia, Dion Zappe

Blood Press· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.
Michael A Weber, Michael Bloch, George L Bakris, Matthew R Weir, Dion H Zappe

J Clin Hypertens (Greenwich)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
Giuseppe Mancia, Sverre E Kjeldsen, Dion H Zappe, Björn Holzhauer, Tsushung A Hua

Eur Heart J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on 'Time of administration important? Morning versus evening dosing of valsartan'.
Dion H Zappe, Paolo Palatini

J Hypertens· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time of administration important? Morning versus evening dosing of valsartan.
Dion H Zappe, Nora Crikelair, Albert Kandra, Paolo Palatini

J Hypertens· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial.
Per H Skoglund, Per Svensson, Joline Asp, Björn Dahlöf, Sverre E Kjeldsen, Dion H Zappe

J Clin Hypertens (Greenwich)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study.
Bryan Williams, John R Cockcroft, Kazuomi Kario, Dion H Zappe, Pamela Cardenas

BMJ Open· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease.
George Bakris, Alexandros Briasoulis, Bjorn Dahlof, Kenneth Jamerson, Michael A Weber, Dion Zappe

Am J Cardiol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
Michael A Weber, George L Bakris, Allen Hester, Matthew R Weir, Tsushung A Hua, Dion Zappe

Am J Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
Michael A Weber, Kenneth Jamerson, George L Bakris, Matthew R Weir, Dion Zappe

Lancet· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
Michael A Weber, Stevo Julius, Sverre E Kjeldsen, Yan Jia, Hans R Brunner, Dion H Zappe

J Hypertens· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen.
Daniel Hayoz, Dion H Zappe, Marie A R Meyer, Inyoung Baek, Albert Kandra

J Clin Hypertens (Greenwich)· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home and clinic blood pressure responses in elderly individuals with systolic hypertension.
William C Cushman, Daniel A Duprez, Howard S Weintraub, Das Purkayastha, Dion Zappe

J Am Soc Hypertens· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?
Prakash C Deedwania, Dion H Zappe, Brent M Egan, Das Purkayastha, Rita Samuel

J Clin Hypertens (Greenwich)· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.
Thomas D Giles, Thomas Alessi, Das Purkayastha, Dion Zappe

J Clin Hypertens (Greenwich)· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis